Bioventus (BVS) Other financing activities (2020 - 2026)
Bioventus' (BVS) quarterly Other financing activities came in at -$241000.0 in Q2 2026, down 15.31% on a YoY basis from -$284570.6 in Q2 2025, and down 9.55% quarter-over-quarter from -$220000.0 in Q1 2026.
Powered by 
Analysis
Bioventus (BVS) Other financing activities (2020 - 2026) Analysis & Trends
Bioventus (BVS) has reported Other financing activities for 7 consecutive years, with -$241000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other financing activities fell 15.31% year-over-year to -$241000.0; the trailing twelve-month figure through Jun 2026 stood at -$876000.0 (down 176.77% YoY), and the FY2025 full-year result was -$827000.0, down 170.08% from the prior year.
- Other financing activities slipped to -$241000.0 in Q2 2026 per BVS's latest filing, from -$220000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $4.0 million in Q4 2023 and bottomed at -$241000.0 in Q2 2026.
- Historically, Other financing activities has averaged $196555.6 across 5 years, with a median of -$175500.0 in 2023.
- The widest YoY moves for Other financing activities: up 36418.18% in 2023, down 983.33% in 2023.
- Over 5 years, Other financing activities stood at -$11000.0 in 2022, then soared by 36418.18% to $4.0 million in 2023, then slumped by 56.35% to $1.7 million in 2024, then slumped by 111.93% to -$208000.0 in 2025, then slipped by 15.87% to -$241000.0 in 2026.
- According to Business Quant data, Other financing activities over the past three periods registered -$241000.0, -$220000.0, and -$208000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | -241,000.00 |
| Mar 28, 2026 | -220,000.00 |
| Dec 31, 2025 | -208,000.00 |
| Sep 27, 2025 | -207,000.00 |
| Jun 28, 2025 | -209,000.00 |
| Mar 29, 2025 | -203,000.00 |
| Dec 31, 2024 | 1.74 Mn |
| Sep 28, 2024 | -191,000.00 |
| Jun 29, 2024 | -190,000.00 |
| Mar 30, 2024 | -183,000.00 |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | -168,000.00 |
| Jul 1, 2023 | -130,000.00 |
| Apr 1, 2023 | -36,000.00 |
| Dec 31, 2022 | -11,000.00 |
| Oct 1, 2022 | 22,000.00 |
| Jul 2, 2022 | -12,000.00 |
| Apr 2, 2022 | -14,000.00 |
| Jul 3, 2021 | -2.63 Mn |
| Apr 3, 2021 | 110.41 Mn |